KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash from Financing Activities (2016 - 2025)

LifeMD (LFMD) has disclosed Cash from Financing Activities for 14 consecutive years, with -$788562.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 507.68% year-over-year to -$788562.0, compared with a TTM value of -$13.4 million through Dec 2025, down 304.61%, and an annual FY2025 reading of -$13.4 million, down 304.61% over the prior year.
  • Cash from Financing Activities was -$788562.0 for Q4 2025 at LifeMD, up from -$8.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $39.3 million in Q4 2021 and bottomed at -$8.7 million in Q3 2025.
  • Average Cash from Financing Activities over 5 years is $4.0 million, with a median of -$763737.5 recorded in 2022.
  • The sharpest move saw Cash from Financing Activities surged 1649.16% in 2023, then crashed 558.85% in 2025.
  • Year by year, Cash from Financing Activities stood at $39.3 million in 2021, then crashed by 95.26% to $1.9 million in 2022, then soared by 671.21% to $14.4 million in 2023, then tumbled by 100.9% to -$129765.0 in 2024, then plummeted by 507.68% to -$788562.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for LFMD at -$788562.0 in Q4 2025, -$8.7 million in Q3 2025, and -$3.1 million in Q2 2025.